Australia - English - Department of Health (Therapeutic Goods Administration)

royal adelaide hospital radiopharmacy - antimony trisulfide -

Malta - English - Medicines Authority

institute of isotopes co. ltd h-1121 budapest, konkoly-thege miklós út 29-33, hungary - tetrakis, methoxy isobutyl, isonitrile, copper, tetrafluorolborate - kit for radiopharmaceutical preparation powder for solution for injection - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg - diagnostic radiopharmaceuticals

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rotop radiopharmacy gmbh - ioflupane (i-123) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rotop radiopharmacy gmbh - ioflupane (i-123) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)

United States - English - NLM (National Library of Medicine)

rotop pharmaka gmbh - 2,3-dimercaptosuccinic acid (unii: 4s9ju7xf01) (2,3-dimercaptosuccinic acid - unii:4s9ju7xf01) - 2,3-dimercaptosuccinic acid 1 mg - rotop - dmsa is a radiodiagnostic pharmaceutical. the kit contains the non-radioactive powder for reconstitution of the [99m tc]technetium succimer injection solution ([99m tc]-dmsa). the sodium [99m t]pertechnetat which is needed for the preparation is not part of this kit. after labelling with sodium [99m tc]technetium pertechnetat solution, rotop - dmsa is used for static renal scintigraphy when adequate diagnostics are not possible using other diagnostic procedures (such as ultrasound): - to identify focal renal parenchymal changes (e.g. in the case of renal infarction) - to identify norm variants such as atypical double kidney, small kidney, dysplastic kidney, horseshoe kidney, as well as to identify ectopic kidneys - to confirm absence of renal function in multicystic kidneys. take special care with rotop – dmsa rotop - dmsa is not suitable for determining global renal function from the dmsa accumulation. in the case of proximal tubulopathies [99m tc]dmsa does not lead to a sufficient diagnostic renal a

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - indium(111in) chloride -

Canada - English - Health Canada

nova scotia health authority - fludeoxyglucose 18f - solution - 200mci - fludeoxyglucose 18f 200mci - diagnostic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - indium (111in) chloride, quantity: 370 mbq/ml - injection, solution - excipient ingredients: hydrochloric acid - for the radiolabelling of approved polyaminocarboxylic acid derivatised monoclonal antibody preparations for in vivo diagnostic imaging procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - indium (111in) chloride, quantity: 370 mbq/ml - injection, solution - excipient ingredients: hydrochloric acid - for the radiolabelling of approved polyaminocarboxylic acid derivatised monoclonal antibody preparations for in vivo diagnostic imaging procedures.